J. San‐Miguel

Statistics

Publications

Citations

H-Index

Active since

2019

Affiliations

Clinica Universidad de Navarra(Current)

Peter MacCallum Cancer Centre

University College London

Universidad de Salamanca

Stanford University

J. San‐Miguel is an author at Clinica Universidad de Navarra specializing in combination immunotherapy, relapsed multiple myeloma, and cancer immunotherapy.

Publications per year

2019–2026

Publications

S824 A PHASE 3 RANDOMIZED, OPEN‐LABEL, MULTICENTER STUDY OF ISATUXIMAB, POMALIDOMIDE, AND LOW‐DOSE DEXAMETHASONE VS POMALIDOMIDE AND LOW‐DOSE DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)

Michel Attal, Paul G. Richardson, S. Vincent Rajkumar et al. · HemaSphere · 2019 · 31 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Cilta-cel in lenalidomide-refractory multiple myeloma (CARTITUDE-4): an updated analysis including overall survival from an open-label, multicentre, randomised, phase 3 trial

Hermann Einsele, J. San‐Miguel, Binod Dhakal et al. · The Lancet Oncology · 2026 · 26 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Report of consensus panel 2 from the 11th international workshop on Waldenström's macroglobulinemia on the management of relapsed or refractory WM patients

Shirley D’Sa, J V Matous, Ranjana H. Advani et al. · Seminars in Hematology · 2023 · 13 citations · Full text

Medicine, Hematology, Clinical Immunology +7

1–3 of 3